Natera (NTRA) has moved into focus after a favorable patent ruling against ArcherDx and Invitae, royalty income tied to MRD products, broad uptake of its Signatera test, and recent progress toward ...

Natera Inc. (NASDAQ:NTRA) said a federal court in Delaware has ruled that the company is entitled to a 30% ongoing royalty on certain revenues tied to infringing minimal residual disease-related ...

Natera (NTRA) on Thursday said the United States District Court for the District of Delaware has ordered an ongoing 30% royalty on certain post-injunction sales tied to its long-running patent dispute ...

Microsatellite Peak Shifts in Polymerase Chain Reaction-Based Fragment Length Data Correlate With Microsatellite Instability Degree and Vary With Mismatch Repair Gene Defects and Tumor Size This was a ...

Noridian Healthcare Solutions opened a draft local coverage determination for gene tests for heritable thoracic aortic disease per a request from Invitae Corp., of San Francisco, which makes a ...

The diagnostic testing company Invitae briefly occupied The Stitch at the former Morrisville Outlet Mall off Airport Boulevard in Morrisville, N.C. Brian Gordon A genetics testing company that agreed ...

In a journey that has seen it launch, get acquired and then launch on its own once again, Citizen Health is back on its feet with a new round of seed funding and a partnership aimed at developing ...

Orange County’s third largest medical diagnostics and testing company is being acquired by a fast-growing Chicago-based firm using artificial intelligence for precision medicine. Aliso Viejo-based ...

The "Global Non-Invasive Prenatal Testing Market Report by Application Component End User Countries and Company Analysis, 2024-2032" report has been added to ResearchAndMarkets.com's offering. Global ...